Bishwas Chamling - Publications

Contemporary Real-World Treatment of Cardiac Transthyretin Amyloidosis with Tafamidis: A Long-Term Multicentre Study.

Journal: ESC heart failure

Published: April 03, 2026

Losartan and prednisolone for post-COVID syndrome and cardiac inflammation: a randomized, double-blind, placebo-controlled trial.

Journal: Nature communications

Published: November 20, 2025

Deep learning to predict left ventricular hypertrophy from the electrocardiogram.

Journal: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology

Published: October 17, 2025

Diagnostic and prognostic value of ECG-predicted hypertension-mediated left ventricular hypertrophy using machine learning.

Journal: Journal of hypertension

Published: February 17, 2025

First-pass perfusion imaging using cardiovascular magnetic resonance in patients with various cardiac implantable electronic devices.

Journal: Clinical research in cardiology : official journal of the German Cardiac Society

Published: January 16, 2025

Low-density lipoprotein cholesterol, lipoprotein(a) and high-sensitivity C-reactive protein are independent predictors of cardiovascular events.

Journal: European heart journal

Published: December 23, 2024

'Hourglass'-shaped heart: midventricular phenotype of hypertrophic cardiomyopathy.

Journal: Cardiology journal

Published: December 05, 2024

Design and rationale of MYOFLAME-19 randomised controlled trial: MYOcardial protection to reduce post-COVID inFLAMmatory heart disease using cardiovascular magnetic resonance Endpoints.

Journal: Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance

Published: July 13, 2024

Real-world characteristics and treatment of cardiac transthyretin amyloidosis: A multicentre, observational study.

Journal: ESC heart failure

Published: June 24, 2024

Effects of sodium-glucose co-transporter inhibitors on individual clinical endpoints and quality of life.

Journal: ESC heart failure

Published: May 30, 2024

A compartment-based myocardial density approach helps to solve the native T1 vs. ECV paradox in cardiac amyloidosis.

Journal: Scientific reports

Published: October 18, 2022

Sphingosine-1-phosphate levels are inversely associated with left ventricular and atrial chamber volume and cardiac mass in men : The Study of Health in Pomerania (SHIP).

Journal: Clinical research in cardiology : official journal of the German Cardiac Society

Published: August 25, 2022